Soluble HLA class I molecules induce natural killer cell apoptosis through the engagement of CD8: evidence for a negative regulation exerted by members of the inhibitory receptor superfamily

被引:75
作者
Spaggiari, GM
Contini, P
Carosio, R
Arvigo, M
Ghio, M
Oddone, D
Dondero, A
Zocchi, MR
Puppo, F
Indiveri, F
Poggi, A
机构
[1] Natl Inst Canc Res, Immunol Lab, Care of CBA, I-16132 Genoa, Italy
[2] Univ Genoa, Dipartimento Med Interna, Clin Immunol Lab, Genoa, Italy
[3] Ist Sci San Raffaele, Lab Tumor Immunol, I-20132 Milan, Italy
关键词
D O I
10.1182/blood.V99.5.1706
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Herein, we show that CD8(dull), CD8(intermediate), and CD8(bright) natural killer (NK) cell clones can be identified. Triggering of CD8 with its natural ligand(s), represented by soluble HLA class 1 (sHLA-1), isolated either from serum of healthy donors or from HLA-1(-)721.221 lymphoblastoid cell line transfected with HLA-A2, -Cw4, and -Bw46 alleles, or HLA-G1 leads to NK cell apoptosis. The magnitude of this effect directly correlated with the level of CD8 expression. sHLA-1-induced apoptosis depends on the interaction with CD8, as it was inhibited by masking this molecule with specific monoclonal antibodies (mAbs). Moreover, sHLA-1 or CD8 cross-linking with specific mAbs elicited intracellular calcium increases, Fas ligand (FasL) messenger RNA transcription, and FasL secretion, which were needed for delivering the death signal. Indeed, this apoptosis was Inhibited by preincubation of NK cell clones with Fas or FasL antagonist mAbs, indicating that the Fas/FasL pathway is Involved. Furthermore, members of the inhibitory receptor superfamily, such as CD94/ NKG2 complex or killer inhibitory receptors, were shown to exert an inhibitory effect on sHLA-1-mediated apoptosis and secretion of FasL These findings suggest that interaction between sHLA-1 and CD8 evokes an apoptotic signal that is down-regulated by inhibitory receptor superfamily that function as survival receptors in NK cells.
引用
收藏
页码:1706 / 1714
页数:9
相关论文
共 41 条
[1]   Increased level of serum HLA class I antigens in patients with systemic lupus erythematosus. Correlation with disease activity [J].
Bresciani, A ;
Pirozzi, G ;
Spera, M ;
Lombardi, ML ;
Ambrosone, L ;
Migliaresi, S ;
Ferrone, S ;
Manzo, C .
TISSUE ANTIGENS, 1998, 52 (01) :44-50
[2]   Natural killer clones recognize specific soluble HLA class I molecules [J].
Carbone, E ;
Terrazzano, G ;
Colonna, M ;
Tuosto, L ;
Piccolella, E ;
Franksson, L ;
Palazzolo, G ;
PerezVillar, JJ ;
Fontana, S ;
Karre, K ;
Zappacosta, S .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1996, 26 (03) :683-689
[3]   RECOGNITION BY CD8 ON CYTOTOXIC LYMPHOCYTES-T IS ABLATED BY SEVERAL SUBSTITUTIONS IN THE CLASS-I ALPHA-3 DOMAIN - CD8 AND THE T-CELL RECEPTOR RECOGNIZE THE SAME CLASS-I MOLECULE [J].
CONNOLLY, JM ;
HANSEN, TH ;
INGOLD, AL ;
POTTER, TA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (06) :2137-2141
[4]   CLASS-I MHC ALPHA-3-DOMAIN CAN FUNCTION AS AN INDEPENDENT STRUCTURAL UNIT TO BIND CD8-ALPHA [J].
FAYEN, J ;
HUANG, JH ;
MEYERSON, H ;
ZHANG, DX ;
GETTY, R ;
GREENSPAN, N ;
TYKOCINSKI, M .
MOLECULAR IMMUNOLOGY, 1995, 32 (04) :267-275
[5]   Soluble HLA-G1 triggers CD95/CD95 ligand-mediated apoptosis in activated CD8+ cells by interacting with CD8 [J].
Fournel, S ;
Aguerre-Girr, M ;
Huc, X ;
Lenfant, F ;
Alam, A ;
Toubert, A ;
Bensussan, A ;
Le Bouteiller, P .
JOURNAL OF IMMUNOLOGY, 2000, 164 (12) :6100-6104
[6]   Soluble HLA class I, HLA class II, and Fas ligand in blood components: A possible key to explain the immunomodulatory effects of allogeneic blood transfusions [J].
Ghio, M ;
Contini, P ;
Mazzei, C ;
Brenci, S ;
Barberis, G ;
Filaci, G ;
Indiveri, F ;
Puppo, F .
BLOOD, 1999, 93 (05) :1770-1777
[7]  
GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440
[8]   THE T-CELL RECEPTOR AS A MULTICOMPONENT SIGNALING MACHINE - CD4/CD8 CORECEPTORS AND CD45 IN T-CELL ACTIVATION [J].
JANEWAY, CA .
ANNUAL REVIEW OF IMMUNOLOGY, 1992, 10 :645-674
[9]   METHODS TO STUDY PEPTIDES ASSOCIATED WITH MHC CLASS-I MOLECULES [J].
JOYCE, S ;
NATHENSON, SC .
CURRENT OPINION IN IMMUNOLOGY, 1994, 6 (01) :24-31
[10]  
Kambayashi T, 2001, EUR J IMMUNOL, V31, P869, DOI 10.1002/1521-4141(200103)31:3<869::AID-IMMU869>3.3.CO